undamentalytics Newsletter
Sign in

Teladoc Health, Inc. cash flow statement

In fiscal 2025, Teladoc Health, Inc.'s operations generated $294m of cash; it spent $8.9m on capital projects, leaving free cash flow of $285m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Cash from operations−6−11−47−52−34−530−54194189350294294268
Depreciation and amortisation125819363969204256————
Stock-based pay01383144674763032182021468051
Capital spending01623444916111196
Free cash flow−6−12−53−54−37−926−58185173339283285262
Free cash flow after stock pay−7−13−57−62−68−53−40−533−117−45137137205211
Share buybacks00————————————
Shares issued——163025933100——————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: TDOC vs VEEVTDOC vs TEMTDOC vs WAY

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Teladoc Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Teladoc Health, Inc.